JP2024508780A5 - - Google Patents

Info

Publication number
JP2024508780A5
JP2024508780A5 JP2023550150A JP2023550150A JP2024508780A5 JP 2024508780 A5 JP2024508780 A5 JP 2024508780A5 JP 2023550150 A JP2023550150 A JP 2023550150A JP 2023550150 A JP2023550150 A JP 2023550150A JP 2024508780 A5 JP2024508780 A5 JP 2024508780A5
Authority
JP
Japan
Prior art keywords
group
compound according
item
alkyl
nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023550150A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024508780A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/000074 external-priority patent/WO2022175749A1/en
Publication of JP2024508780A publication Critical patent/JP2024508780A/ja
Publication of JP2024508780A5 publication Critical patent/JP2024508780A5/ja
Pending legal-status Critical Current

Links

JP2023550150A 2021-02-18 2022-02-18 オリゴヌクレオチドおよび炭水化物をコンジュゲートするための組成物 Pending JP2024508780A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163151060P 2021-02-18 2021-02-18
US63/151,060 2021-02-18
PCT/IB2022/000074 WO2022175749A1 (en) 2021-02-18 2022-02-18 Compositions for conjugating oligonucleotides and carbohydrates

Publications (2)

Publication Number Publication Date
JP2024508780A JP2024508780A (ja) 2024-02-28
JP2024508780A5 true JP2024508780A5 (cg-RX-API-DMAC7.html) 2025-02-26

Family

ID=81386899

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023550150A Pending JP2024508780A (ja) 2021-02-18 2022-02-18 オリゴヌクレオチドおよび炭水化物をコンジュゲートするための組成物

Country Status (5)

Country Link
US (1) US20250034561A1 (cg-RX-API-DMAC7.html)
EP (1) EP4294449A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024508780A (cg-RX-API-DMAC7.html)
CN (1) CN117222434A (cg-RX-API-DMAC7.html)
WO (1) WO2022175749A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116444589B (zh) * 2023-06-15 2023-09-19 北京悦康科创医药科技股份有限公司 新型GalNAc化合物及其硫代寡核苷酸缀合物和偶联方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3121281B1 (en) 2007-08-27 2021-03-31 1Globe Health Institute LLC Compositions of asymmetric interfering rna and uses thereof
PL2992098T3 (pl) * 2013-05-01 2019-09-30 Ionis Pharmaceuticals, Inc. Kompozycje i sposoby modulowania ekspresji hbv i ttr
JOP20160211B1 (ar) * 2015-10-01 2021-08-17 Arrowhead Pharmaceuticals Inc تراكيب وأساليب لتثبيط تعبير جيني للـ lpa
WO2018185253A1 (en) * 2017-04-05 2018-10-11 Silence Therapeutics Gmbh Ligand modified double-stranded nucleic acids
SG11202105900UA (en) * 2018-12-10 2021-07-29 Amgen Inc CHEMICALLY-MODIFIED RNAi CONSTRUCTS AND USES THEREOF
TW202103698A (zh) * 2019-04-18 2021-02-01 美商健生醫藥公司 用於治療b型肝炎病毒感染之組合療法
EP4126967A1 (en) * 2020-03-23 2023-02-08 Amgen Inc. Monoclonal antibodies to chemically-modified nucleic acids and uses thereof
KR20230104200A (ko) * 2020-11-05 2023-07-07 암젠 인크 LPA-표적화된 RNAi 작제물을 이용하여 죽상경화성 심혈관질환을 치료하는 방법
WO2022152869A1 (en) * 2021-01-15 2022-07-21 Janssen Sciences Ireland Unlimited Company Use of oligonucleotides for individuals with hepatic impairment

Similar Documents

Publication Publication Date Title
CN111343994B (zh) 用于抑制血管生成素-样3 (ANGPTL3)的表达的RNAi剂和组合物以及使用方法
JP2022544587A5 (cg-RX-API-DMAC7.html)
JP6978099B2 (ja) 4’−リン酸アナログ及びそれを含むオリゴヌクレオチド
JP2022533841A5 (cg-RX-API-DMAC7.html)
CN109562188B (zh) 与三价糖缀合物连接的核酸
JP2022533722A5 (cg-RX-API-DMAC7.html)
CN105164261B (zh) 用于增强的细胞摄取的化合物和方法
JP7748500B2 (ja) トリループを含む二本鎖核酸インヒビター分子
JP2020533334A (ja) アポリポタンパク質C−III(APOC3)の発現を阻害するためのRNAi剤および組成物
JP2022534069A5 (cg-RX-API-DMAC7.html)
US20130059902A1 (en) Methods and compositions useful in treatment of diseases or conditions related to repeat expansion
US20180318330A1 (en) Compounds and methods for modulating c90rf72
JP2021503929A5 (cg-RX-API-DMAC7.html)
JP2021503941A5 (cg-RX-API-DMAC7.html)
KR20240096846A (ko) 알파-1 항트립신 (AAT) RNAi 작용제, AAT RNAi 작용제를 포함하는 조성물, 및 사용 방법
JP2022535708A5 (cg-RX-API-DMAC7.html)
JP2022533419A5 (cg-RX-API-DMAC7.html)
JP2022533421A5 (cg-RX-API-DMAC7.html)
CN105121452A (zh) 三环核苷和由其制备的寡聚化合物
CN120118909B (zh) 靶向调控LPA基因表达的siRNA双链体及其在预防和治疗心脑血管相关疾病中的用途
US6017895A (en) Oligonucleotides possessing zwitterionic moieties
JP2025526994A5 (cg-RX-API-DMAC7.html)
EP4353266A1 (en) Ligand-bound nucleic acid complex
CN120485189B (zh) 靶向调控LPA基因表达的siRNA及其用途
HK40084990A (en) 4'-oxymethylphosphonate nucleotide analogs and oligonucleotides comprising the same